SCHEMBL22635632

SCHEMBL22635632

CNS(=O)(=O)c1ccc(Nc2ccc(C(F)(F)F)cc2)c(C(=O)NSNC(N)=O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TEAD1 P28347 2/20 0.48
▸ YAP1 P46937 1/20 0.48
▸ TNNI3K Q59H18 2/20 0.43
▸ AKR1C3 P42330 1/20 0.43
▸ AKR1C2 P52895 1/20 0.43
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ ALDH3A1 P30838 4/20 0.40
▸ MAPT P10636 3/20 0.38
▸ LMNA P02545 2/20 0.38
▸ TP53 P04637 2/20 0.38
▸ KDM1A O60341 1/20 0.38
▸ CA12 O43570 1/20 0.37
▸ CA1 P00915 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ CA9 Q16790 1/20 0.37
▸ FBP1 P09467 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20766300 0.85 TEAD1 (0.53) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL20767220 0.83 TEAD1 (0.49) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL20766837 0.80 TEAD1 (0.54) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL23701552 0.78 RXFP1 (0.51) AKR1C3AKR1C2
SCHEMBL20779708 0.76 TEAD1 (0.51) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL20779892 0.74 TEAD1 (0.62) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL22635666 0.71 ALDH1A1 (0.58) TEAD1YAP1TNNI3KMEN1KMT2A
SCHEMBL22719765 0.71 TEAD1 (0.56) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL20779642 0.71 TEAD1 (0.56) TEAD1YAP1TNNI3KAKR1C3AKR1C2
SCHEMBL29504945 0.71 TEAD1 (0.56) TEAD1YAP1TNNI3KAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3691623-B1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS INC (US) 2022-10-05 — — EP disclosed
US-11192865-B2 Benzosulfonyl compounds VIVACE THERAPEUTICS, INC. (US) 2021-12-07 — — US disclosed
US-20200354325-A1 BENZOSULFONYL COMPOUNDS VIVACE THERAPEUTICS, INC. 2020-11-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11192865-B2 Benzosulfonyl compounds YAP1, TEAD2, TEAD1 TEAD1 3/4885YAP1 1/4885TNNI3K 402/4885
US-20200354325-A1 BENZOSULFONYL COMPOUNDS YAP1, TEAD2, TEAD1 TEAD1 3/4885YAP1 1/4885TNNI3K 402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback